إعلان
إعلان

SRTS

SRTS logo

Sensus Healthcare, Inc

3.70
USD
برعاية
-0.01
-0.29%
٣٠ ديسمبر, ١٥:٥٩ UTC -5
مغلق
exchange

قبل الإفتتاح

3.83

+0.13
+3.54%

تقارير أرباح SRTS

النسبة الإيجابية المفاجئة

SRTS تفوق 24 من 37 آخر التقديرات.

65%

التقرير التالي

بيانات التقرير القادم
٠٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$8.51M
/
-$0.07
التغير الضمني من Q3 25 (Revenue/ EPS)
+23.65%
/
+16.67%
التغير الضمني من Q4 24 (Revenue/ EPS)
-34.86%
/
-177.78%

Sensus Healthcare, Inc earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, SRTS reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 38.08% surprise. Revenue reached 6.88 مليون, compared to an expected 6.44 مليون, with a 6.91% difference. The market reacted with a +19.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 8.51 مليون USD, implying an increase of 16.67% EPS, and increase of 23.65% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Sensus Healthcare, Inc reported EPS of -$0.06, beating estimates by 38.08%, and revenue of $6.88M, 6.91% above expectations.
The stock price moved up 19.32%, changed from $3.52 before the earnings release to $4.20 the day after.
The next earning report is scheduled for ٠٣ فبراير ٢٠٢٦.
Based on 5 analysts, Sensus Healthcare, Inc is expected to report EPS of -$0.07 and revenue of $8.51M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان